SCHEMBL16178340

SCHEMBL16178340

CNC(=O)[C@@]1(O)[C@@H](C)O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@@H]1O

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 15/20 0.73
▸ ADORA2A P29274 6/20 0.69
▸ ADORA1 P30542 5/20 0.69
▸ CYP3A4 P08684 2/20 0.69
▸ MAPK1 P28482 2/20 0.69
▸ ADORA2B P29275 2/20 0.69
▸ CYP1A2 P05177 1/20 0.69
▸ MAPT P10636 1/20 0.69
▸ LMNA P02545 1/20 0.69
▸ BLM P54132 1/20 0.69
▸ PMP22 Q01453 1/20 0.69
▸ CYP2D6 P10635 1/20 0.69
▸ PKM P14618 1/20 0.69
▸ TSHR P16473 1/20 0.69
▸ NFKB1 P19838 1/20 0.69
▸ ABCG2 Q9UNQ0 1/20 0.69
▸ HTR2C P28335 1/20 0.69
▸ HTR2B P41595 1/20 0.69
▸ RXFP1 Q9HBX9 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ib-Meca SCHEMBL29572081 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL8922766 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL29634441 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL10089200 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL10089244 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL465039 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL29384499 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL448115 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL20905217 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1
Ib-Meca SCHEMBL12265127 0.81 ADORA3 (1.00) ADORA3ADORA2AADORA1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9301968-B2 Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient Hayashibara Co., Ltd. (JP) 2016-04-05 — — US disclosed
US-20140315849-A1 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, CONTAINING ADENOSINE N1-OXIDE AS AN EFFECTIVE INGREDIENT Hayashibara Co., Ltd. (JP) 2014-10-23 — — US disclosed
Send feedback